Independent report

Evaluating BBSRC investments in industrial biotechnology research

This report summarises the conclusions of an expert review panel that was established to conduct an evaluation of BBSRC's investments in IB research.

From:
BBSRC
Published:

Documents

BBSRC Industrial Biotechnology report (PDF)

, 11 MB

If you cannot open or read this document, you can ask for a different format.

Request a different format

Email web@ukri.org, telling us:

  • the name of the document
  • what format you need
  • any assistive technology you use (such as type of screen reader).

Find out about our approach to the accessibility of our website.

Details

Industrial Biotechnology (IB) is a set of cross-disciplinary approaches that use biological resources for the production and processing of materials, chemicals and energy carriers with the principal aim of reducing greenhouse gas emissions by replacing fossil chemical feedstocks or fossil chemical powered processes.

Biotechnology and Biological Sciences Research Council’s (BBSRC) current annual expenditure on the IB portfolio is approximately £29 million across a variety of investment mechanisms.

This document summarises the views and conclusions of a specialist evaluation panel, who conducted an independent evaluation of the effectiveness and impact of BBSRC’s investments in IB research.

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.